TITLE

COMMENTARY: Clopidogrel plus aspirin did not differ from aspirin alone for reducing MI, stroke, and CV death in high-risk atherothrombosis

AUTHOR(S)
Ballew, Kenneth A.
PUB. DATE
September 2006
SOURCE
ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p33
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents comments on the study by D.L. Bhatt and colleagues to assess the effectiveness of clopidogrel and aspirin in the prevention of atherothrombosis. According to the author, there was no effect in using dual therapy over aspirin. The author feels that if dual therapy is beneficial for acute coronary syndromes for a short-term then there may be some patients for whom, it will be beneficial for a long-term.
ACCESSION #
22493472

 

Related Articles

  • Antiplatelet therapy and the vascular tree. Blann, A. // Heart;Jan2006, Vol. 92 Issue 1, p3 

    The article discusses the use of aspirin plus clopidogrel as an adjunct to percutaneous coronary intervention. Aspirin is effective in reducing the risk of primary and secondary cardiovascular events, such as myocardial infarction and stroke, and is a mainstay of both the adjuvant treatment of...

  • Fine line between benefit and harm conferred by prophylactic aspirin.  // PharmacoEconomics & Outcomes News;6/4/2005, Issue 479, p8 

    Discusses research being done on epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke. Reference to a study by M. R. Nelson et al, published in the 2005 issue of "British Medical Journal"; Risks associated with the improper...

  • An aspirin a day reduces complications of diabetes. Guthrie, Ellen Whipple // Pharmacy Today;Oct2004, Vol. 10 Issue 10, p7 

    This article presents information on use of aspirin in diabetics. Patients with diabetes have a two- to fourfold increase in risk of dying from complications of cardiovascular disease (CVD). Aspirin decreases the risk of heart attacks and strokes. Therefore, it only makes sense that aspirin...

  • Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. Hippisley-Cox, Julia; Coupland, Carol // BMJ: British Medical Journal (International Edition);6/11/2005, Vol. 330 Issue 7504, p1366 

    Presents a study to determine the comparative risk of myocardial infarction in patients treated with cyclo-oxygenase-2 and other non-steroidal anti-inflammatory drugs (NSAIDs) in primary care during 2000 and 2004, the risks in patients with and without coronary heart disease, as well as the risk...

  • Review: Evidence from observational studies, but not randomized trials, suggests that long-term aspirin prevents colorectal cancer: COMMENTARY. Lebwohl, Benjamin; Neugut, Alfred I. // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p15 

    The authors reflect on a study, conducted by C. Dubá and colleagues, which focuses on the effectiveness of aspirin in preventing colorectal cancer. The authors view that Dubá and colleagues highlight notable discrepancies between randomized controlled trials (RCTs) and observational...

  • NSAIDs and cardiovascular disease. Patrignani, Paola; Capone, Marta L.; Tacconelli, Stefania // Heart;Apr2008, Vol. 94 Issue 4, p395 

    The authors reflect on Non-steroidal anti-inflammatory drugs (NSAIDS) and cardiovascular diseases. According to the authors, non-steroidal drugs are a group of chemically heterogeneous agents that treats symptoms of acute pain and chronic inflammatory and degenerative joint diseases like...

  • Inappropriate aspirin use for primary prevention of CVD.  // Reactions Weekly;Jan2015, Vol. 1535 Issue 1, p10 

    The article offers information regarding the inappropriate aspirin use for preventing cardiovascular disease in patients with a 10-year risk.

  • NSAIDs and cardiovascular disease. Patrignani, Paola; Capone, Marta L.; Tacconelli, Stefania // Heart;Apr2008, Vol. 94 Issue 4, p395 

    The authors reflect on Non-steroidal anti-inflammatory drugs (NSAIDS) and cardiovascular diseases. According to the authors, non-steroidal drugs are a group of chemically heterogeneous agents that treats symptoms of acute pain and chronic inflammatory and degenerative joint diseases like...

  • ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN. Jneid, Hani // Methodist DeBakey Cardiovascular Journal;Dec2010, Vol. 6 Issue 4, p37 

    The article discusses the use of aspirin for primary prevention of cardiovascular disease (CVD) in women. As reported, many randomized controlled trials (RCTs) have examined the benefits of aspirin in the prevention for CVD which accounts for 34% of overall mortality in the U.S. The use of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics